Akari Therapeutics PLC (AKTX)
1.525
+0.04
(+3.04%)
USD |
NASDAQ |
May 17, 16:00
1.525
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 33.61M |
Adaptimmune Therapeutics PLC | 0.00 |
Biodexa Pharmaceuticals Plc | 0.00 |
NuCana PLC | -- |